The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis

Human Reproduction Update

Volumn 15, Issue 1, 2009, Pages 139-151

  Wright, Caroline F ^a   Burton, Hilary ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cell free fetal DNA (cffDNA); Cell free fetal nucleic acids; Genetic diagnosis; Non invasive prenatal diagnosis (NIPD); Prenatal diagnosis

Indexed keywords

CELL FREE FETAL NUCLEIC ACID; NUCLEIC ACID; RHESUS ANTIGEN; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; DIAGNOSTIC VALUE; DNA DETERMINATION; DOWN SYNDROME; FETUS; GENE EXPRESSION PROFILING; GENETIC DISORDER; GENETIC RISK; HUMAN; MATERNAL BLOOD; MEDLINE; MONOGENIC DISORDER; NON INVASIVE MEASUREMENT; NUCLEOTIDE SEQUENCE; PRENATAL CARE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; SEX DETERMINATION; X CHROMOSOME LINKED DISORDER;

ANEUPLOIDY; DNA; FEMALE; FETAL DISEASES; FETUS; GENETIC MARKERS; GENETIC SCREENING; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRENATAL DIAGNOSIS; SEX DETERMINATION (GENETICS);

EID: 58049202879     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmn047     Document Type: Article

References (136)

1. Al-Yatarna MK, Mustafa AS, Ali S, Abraham S, Khan Z, Khaja N. Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction. Prenat Diag 2001; 21 399 402.
2. Albenry M. Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent ND, Soothill PW. Free fetal, DNA in maternal plasma in anembryonic pregnancies: Confirmation that the origin is the trophoblast. Prenat Diagn 2007;27:415-418.
3. Amicucci P, Gennarelli M, Noyelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000;46:301-302.
4. Avent ND. The mesus blood group system: Insights from recent advances in molecular biology. Transfus Med Rev 1999;13:245 266.
5. Avent ND, Chitty LS. Non-invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound. Prenat Diagn 2006;26: 598-603.
6. Avert ND, Reid ME. The Rh blood group system: A review. Blood 2000: 95:375-387.
7. Avent ND, Plummer ZE, Madgett TE, Maddocks DG, Soothill PW. Post-genomics studies and their application to non-invasive prenatal diagnosis. Sem Fetal Neonat Med 2008;13:91-98.
8. Babochkina T, Mergenthaler S, De Napoli G. Hristoskova S, Sevgi T, Holzgreve W, Hahn S. Numerous erythroblasts in maternal blood are impervious to fluorescent in situ hybridisation analysis, a feature related to a dense compact nucleus with apoptotic character. Hoematologica 2005;90:740-745.
9. Baird PA, Anderson TW, Newcombe HB, Lowry RS. Genetic disorders in children and young adults: A population study. Am J Hum Genet, 1988; 42:677-693.
10. Bartha JL, Finning K, Soothill PW. Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency. Obstet Gynecol 2003;101: 1135-1136.
11. Bauer M, Hutterer G, Eder M, Maier S, Leshane E, Johnson KL, Peter 1, Bianchi DW, Pertl B. A prospective analysis of cell-free fetal DNA concentration in matemai plasma as an indicator for adverse pregnancy outcome. Prenat Diagn 2006;26:831-836.
12. Benachi A. Yamgnane A, Olivi M, Dumez Y, Gautier E, Costa JM. Impact of formaldehyde on the in vitro proportion of fetal DNA in maternal plasrna and serium. Clin Chem 2005;51:242-244.
13. Bianchi DW, Fetal cells in the maternal circulation: Feasibility for prenatal diagnosis. Br J Haematol 1999;105:574-583.
14. Bianchi DW, Flint AF, Pizzimenti HIP, Knoll JHM, Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Nod Acad Sci USA 1990;87:3279-3283.
15. Bianchi DW, Zickwolf GK Weil GJ, Sylvester S, DeMaria MAL Male fetal progenitor cells persist in maternal blood for as long as 27 years postparturn. Proc Natl Acad Sci USA 1996;93:705-708.
16. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997;61:822-829.
17. Birch L, Enesh CA, O'Donoghue K, Barigye O, Fisk NM, Keer JT. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 2005; 51 312-320.
18. Bischoff FZ, Lewis DE, Simpson JL. Cell-free fetal DNA in maternal blood: Kinetics, source and structure. Hum Reprod Update 2005; 11:59-67.
19. Boon EMJ, Schlecht HB, Martin PG, Daniels G, Vossen RHAM, den Dunnen JT, Bakker B, Elles R. Y chromosome detection by real time PCR and pyrophosphorolysis-activated pollymerisation using free fetal DNA isolated from maternal plasma. Prenot Diagn 2007;27:932-937.
20. Chan KCA, Zhang J, Hui ABY, Wong N, Lau TK, Leung TN, Lo KW, Huang DWS, Lo YMD. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004;50:88-92.
21. Chan CL, Blyth E, Chan CH. Attitudes to and practices regarding sex selection in China. Prenat Diagn 2006a;26:610-613.
22. Chan KCA, Ding C, Gerovassili A, Yeung SW, Chiu RWK, Leung TN, Lau TK, Chim SSC, Chung GTY, Nicolaides KH et al. Hypermethylated RASSFIA in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006b: 52:2211-2218.
23. Cheung Mc, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 1996;14:264-268.
24. Chim SSC, Tung YK, Chiu RWK, Lau T-K, Leung TN, Chan LYS, Oudejans CBM, Ding C, Lo YMD. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005;102 14753-14758.
25. Chim SSC, Jin S, Lee TYH, Lun FMF, Lee WS, Chan LYS, Jin Y, Yang N, Tong YK, Leung TY et al. Systematic search for placental DNA-methylation markers on chrornosome 21: Toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 2008a; 54:500-511.
26. Chim SSC, Shing TKF, Hung ECW, Leung Ty, Lau Tk, Chiu RWK, Dennis Lo YM. Detection and characterization of placental MicroRNAs in maternal plasma. Clin Chem 2008b;54:482-490.
27. Chinnapapagari SKR, Holzgreve W, Lapaire 0, Zimmermann B, Hahn S. Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic adds (DNA and mRNA) in maternal plasma. Clin Chem 2005;51:652-655.
28. Chitty L, Mistry B, Hogg J, Meaney C, Thomasson L, Norbury G, Daniels G, Finning K, Martin P. Prospective register of outcomes of frLe-fetal DNA testing (PROOF) - results of the first year's audit. Newsletter of the British Society for Human Genetics 2007;37:8-9.
29. Chiu RWK, Poon LLM, Lau TK, Leung TN, Wong EMC, Lo YMD. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001;47:1607-1613.
30. Chiu RWK, Lau TK, Cheung PT, Gong ZQ, Leung TN, Lo YMD. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: A feasibility study. Clin Chem 2002a; 48:778-780.
31. Chiu RWK, Lau TK, Leung TN, Chow KCK, Chui DH, Lo YD. Prenatal exclusion of [beta] thalassaerria major by examination of maternal plasma. Lancet 2002b;360:998-1000,
32. Chiu RWK, Lui Wb, Cheung Mc, Kumta N, Farina A, Banzola I, Grotti S, Rizzo N, Haines CJ, Lo YMD. Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma. Clin Chem 2006;52:313-316.
33. Chung GTY, Chiu RWK, Chan KCA, Lau TK, Leung TN, Lo YMD. Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. Clin Chem 2005;51:655-658.
34. Costa JM, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 2002;346:1502.
35. Use of c.ffNA in maternal blood for NIPD
36. Daniels G. The molecular genetics of blood group polymorphism. Transplant Immunol 2005;14:143-153.
37. Deng Z, Wu G, Li Q, Zhang X, Liang Y, Li D, Gao S, Lan Y. Noninvasive genotyping of 9 Y-chromosome specific STR loci using circulatory fetal DNA in maternal plasma by multiplez PCR. Prenatal Diag 2006;26 362-368.
38. Deviin L, Morrison PJ. Mosaic Down's syndrome prevalence in a complete population study. Arch Dis Child2004;89:1177-1117b.
39. Dhallan R, Au WC, Mattagaiasingh S, Emche S. Bayliss P, Damewood M, Cronin M, Chou V, Mohr M. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA 2004; 291: 1114-1119.
40. Dhailan R, Guo X, Emche S, Damewood M, Bayliss P, Cronin M, Barry J, Betz J, Franz K, Gold K et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: A preliminary study. Lancet 2007;369:474-481.
41. Ding C, Chui RWK, Lau TK, Leung TN, Chan LC, Chan AYY, Charoenkwan P, Ng ISL, Law HyMaESK et al. MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Nad Acad Sci USA 2001;101: 10762-10767.
42. Fan HC, Blumenfield YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive, diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. PNAS 2008; doi: 10.1073/pnas.0808319105.
43. Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem 2007;79:7576-7579.
44. Farina A. Sekizawa A, Sugito Y, Iwasaki M, Jimbo M,. Okai T. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk non-symptomatic patients. Prenatal Diag 2004;24:83-86.
45. Fejgin MD, Diukman R, Cotton Y, Weinstein G, Amiel A. Fetal cells in the uterine cervix: A source for early non-invasive prenatal diagnosis. Prenat Diagn 2001;21:619-621.
46. Finning K, Martin P, Summers J, Daniels G. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion 2007;47:2126-2133.
47. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: Prospective feasibility study. Br Med J 2008; 336:816-818.
48. Fucharoen G, Tungwiwat W, Ratanasiri T, Sanchaisuriya K, Fucharoen S. Prenatal diagnosis of fetal hemoglobin E gene from maternal plasma. Prenat Diagn 2003;23:393-396.
49. Galbiati S, Smid M, Gambini D, Ferrari A, Restagno G, Viora E, Campogrande M, Calza S, Ferrari M, Cremonesi L. Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 2005; 117 243-248.
50. Ge Q, Bai Y, Liu Z, Liu Q, Yan L, Lu Z. Detection of fetal DNA in maternal plasma by microarray coupled with emulsions PCR. Clin Chim Acta 2006; 369:82-88.
51. Geifman-Holzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood - a meta-analysis. Am J Obstet Gynecol 2006;195:1163-1173.
52. George SM. Millions of missing girls: From fetal sexing to high technology sex selection in India. Prenat Diagn 2006;26 604-609.
53. Gerovassili A, Kypros HN, Thein SL, Rees DC. Cell-free DNA levels in pregnancies at risk of sickle-cell disease and signi.cant ethnic variation. Br J Haematol 2006;135:738-741.
54. Gerovassili A, Garner C, Nicolaides KH, Thein SL, Rees DC. Free fetal DNA in maternal circulation: A potential prognostic marker for chromosome abnormalities? Prenat Diagn 2007;27:104-110.
55. Go ATJI, Visser A, Mulders MAM, Blankenstein MA, van Vugt JMG, Oudejans CBM. Detection of placental transcription factor mRNA in maternal plasma. Clin Chem 2004;50:1413-1414.
56. Go ATJI, Visser A, Mulders MAM, Blankenstein MA, van Vugt JMG, Oudejans CBM. 44 Single-nucleotide polymorphisms expressed by placental RNA: assessment for use in noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2007;53:2223-2224.
57. Gonzalez-Gonzalez C, Garcia-Hoyos M, Trujillo-Tiebas MJ, Rodriguez de Alba M, Lorda-Sanchez I, Diaz-Recasens J, Gallardo E, Ayuso C, Ramos C. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002;22:946-948.
58. Gonzalez-Gonzalez C, Trujillo-Tiebas MJ, Rodriguez de Alba M, Garcia-Hoyos M, Lorda-Sanchez I, Diaz-Recasens J, Ayuso C, Ramos C. Huntington disease - unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn 2003;23:232-234.
59. Grootkerk-Tax MGHM, Soussan AA, de Haas M, Maaskant-van Wijk PA, van der Schoot CE. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion 2006; 46 2142-2148.
60. Hahn S, Zhong XY, Burk MR, Troeger C, Kang A, Holzgreve W. Both maternal and fetal cell-free DNA in plasma fluctuate. Ann NY Acad Sci 2001;945:141-144.
61. Hahn S, Huppertz B, Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood: New tools to study abnormal placentation? Placenta 2005;26:515-526.
62. Honda H, Miharu N, Ohashi Y, Ohama K. Successful diagnosis of fetal gender using conventional PCR analysis of maternal serum. Clin Chem 2001; 47:41-46.
63. Honda H, Miharu N, Ohashi Y, Samura O, Kinutani M, Hara T, Ohama K. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet 2002;110:75-79.
64. Human Genetics Commission. Choosing the future: Genetics and reproductive decision making. July 2004.
65. Illanes S, Denbow M, Kailasam C, Finning K, Soothill PW. Early detection of cell-free fetal DNA in maternal plasma. Early Hum Dev 2007; 83: 563-566.
66. Invernizzi P, Biondi ML, Battezzati PM, Perego F, Selmi C, Cecchini F, Podda M, Simoni G. Presence of fetal DNA in maternal plasma decades after pregnancy. Hum Genet 2002;110:587-591.
67. Jackson L. Fetal cells and DNA in maternal blood. Prenat Diagn 2003;23: 837-846.
68. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001;61:1659-1665.
69. Johnston TA. Haemoglobinopathies in pregnancy. The Obstetrician and Gynaecologist 2005;7:149-157.
70. Landy HJ, Keith LG. The vanishing twin: A review. Hum Reprod Update 1998;4:177-183.
71. Landy HJ, Weiner S, Corson SL, Batzer FR, Bolognese RJ. The "vanishing twin": Ultrasonographic assessment of fetal disappearance in the first trimester. Am J Obstet Gynecol 1982;155:14-19.
72. Lazaros L, Hatzi E, Bouba I, Paraskevaidis E, Georgiou I. Non-invasive prenatal detection of paternal origin Hb Lepore in a male fetus at the 7th week of gestation. Fetal Diagn Ther 2006;21:506-509.
73. Legler TJ, Liu Z, Mavrou A, Finning K, Hromadnikova I, Galbiati S, Meaney C, Hulten M, Crea F, Olsson ML et al. Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn 2007;27:824-829.
74. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37 646-650.
75. Li Y, Holzgreve W, Paget-Christiaens LGC, Gille JJP, Hahn S. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma - case report. Prenat Diagn 2004a;24:896-898.
76. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 2004b;50:1002-1011.
77. Li Y, di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for {beta}-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005;293: 843-849.
78. Li Y, Wenzel F, Holzgreve W, Hahn S. Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: Influence of size fractionation. Electrophoresis 2006; 27: 3889-3896.
79. Li Y, Paget-Christiaens LGC, Gille JJP, Holzgreve W. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 2007;27:11-17.
80. Liu FM, Wang XY, Feng X, Wang W, Ye YX, Chen H. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis. Acta Obset Gyn Scand 2007;86:535-541.
81. Lo YMD, Lo ES, Watson N, Noakes L, Sargent IL, Thilaganathan B, Wainscoat JS. Two-way cell traffic between mother and fetus: Biologic and clinical implications. Blood 1996;88:4390-4395.
82. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487.
83. Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PMK, Redman CWG, Wainscoat JS. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998a;339 1734-1738.
84. Lo YMD, Tein MSC, Lau TK, Haines CJ, Leung TN, Poon PMK, Wainscoat JS, Johnson PK, Chang AMZ, Hjelm NM. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998b;62:768-775.
85. Lo YMD, Lau TK, Zhang J, Leung TN, Chang AMZ, Hjelm NM, Elmes RS, Bianchi DW. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 1999a; 45 1747-1751.
86. Lo YMD, Leung TN, Tein MSC, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CWG. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999b;45:184-188.
87. Lo YMD, Zhang J, Leung TN, Lau TK, Chang AMZ, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999c; 64 218-224.
88. Lo YMD, Lun FMF, Chan KCA, Tsui NBY, Chong KC, Lau TK, Leung TY, Zee BCY, Cantor CR, Chiu RWK. From the cover: Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 2007a;104:13116-13121.
89. Lo YMD, Tsui NBY, Chiu RWK, Lau TK, Leung TN, Heung MMS, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007b;13:218-223.
90. Lurie S, Mamet Y. Red blood cell survival and kinetics during pregnancy. European J Obstet Gynecol Reprod Biol 2000;93:185-192.
91. Mandel P, Metais P. Les acides nucleiques du plasma sanguin chez l'homme. C R Acad Sci Paris 1948;142:241-243.
92. Mantzaris D, Cram D, Healy C, Howlett D, Kovacs G. Preliminary report: correct diagnosis of sex in fetal cells isolated from cervical mucus during early pregnancy. ANZJOG 2005;45:529-532.
93. Mayor S. Denmark halves Down's births by non-invasive screening in early pregnancy. Br Med J 2007;334:1291.
94. Meng JL, Wang XT, Wang Y, Yue YF, Wang X, Chen ZJ. Use of maternal plasma for non-invasive prenatal diagnosis of fetal ABO genotypes. Clin Chem Lab Med 2007;45:981-986.
95. Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM. Routine fetal RHD genotyping with maternal plasma: A four-year experience in Belgium. Transfusion 2008;48:373-381.
96. Mujezinovic F, Al.revic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: A systematic review. Obstet Gynecol 2007;110:687-694.
97. Nasis O, Thompson S, Hong T, Sherwood M, Radcliffe S, Jackson L, Otevrel T. Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis. Clin Chem 2004;50: 694-701.
98. National Down Syndrome Cytogenetic Register. Annual Report, UK National Screening Committee. 2005.
99. Newson AJ. Ethical aspects arising from non-invasive fetal diagnosis. Sem Fetal Neonatal Med 2008;13:103-108.
100. Ng EKO, Tsui NBY, Lau TK, Leung TN, Chiu RWK, Panesar NS, Lit LCW, Chan KW, Lo YMD. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003;100:4748-4753.
101. Norbury G, Norbury CJ. Non-invasive prenatal diagnosis of single gene disorders: How close are we. Sem Fetal Neonat Med 2008;13 76-83.
102. OhmKyvik K, Derom C.Data collection onmultiple births - establishing twin registers and determining zygosity. Early Hum Dev 2006;82 357-363.
103. Oudejans CBM, Go ATJJ, Visser A, Mulders MAM, Westerman BA, Blankenstein MA, van Vugt JMG. Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin Chem 2003;49:1445-1449.
104. Page-Christiaens LGC, Bossers B, van der Schoot CE, de Haas M. Use of bi-allelic insertion/deletion polymorphisms as a positive control for fetal genotyping in maternal blood: First clinical experience. Ann NY Acad Sci 2006;1075:123-129.
105. Pertl B, Sekizawa A, Samura O, Orescovic I, Rahaim PT, Bianchi DW. Detection of male and female fetal DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats. Hum Genet 2000;106:45-49.
106. Pilgrim H, Myfanwy L-J, Rees A. Routine antenatal anti-D prophylaxis for RhD-negative women. Health Technol Assess. In press.
107. Poon LLM, Leung TN, Lau TK, Lo YMD. Presence of fetal RNA in maternal plasma. Clin Chem 2000;46:1832-1834.
108. Poon LLM, Leung TN, Lau TK, Chow KCK, Lo YMD. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem 2002;48:35-41.
109. Randon I, Hauge R, Kjeldsen-ragh J, Fagerhol MK. Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 2003;85:300-306.
110. Reddy UM, Mennuti MT. Incorporating first-trimester Down syndrome studies into prenatal screening: Executive summary of the national institute of child health and human development workshop. Obstet Gynecol 2006; 107:167-173.
111. Rijnders RJP, van der Schoot CE, Bossers B, de Vroede MAMJ, Christiaens GCML. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 2001;98 374-378.
112. Robertson JA. Extending preimplantation genetic diagnosis: Medical and non-medical uses. J Med Ethics 2003;29:213-216.
113. Rouillac-Le Sciellour C, Serazin V, Brossard Y, Oudin O, Le Van Kim C, Colin Y, Guidicelli Y, Menu M, Cartron J-P. Noninvasive fetal RHD genotyping from maternal plasma; use of a new developed Free DNA Fetal Kit RhDw. Transfus Clin Biol 2007;14:572-577.
114. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000; 356:1170.
115. Sekizawa A, Kondo T, Iwasaki M, Watanabe A, Jimbo M, Saito H, Okai T. Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem 2001;47:1856-1858.
116. Sekizawa A, Purwosunu Y, Farina A, Okai T, Takabayashi H, Kita M, Yura H, Kitagawa M. Development of noninvasive fetal DNA diagnosis from nucleated erythrocytes circulating in maternal blood. Prenat Diagn 2007;27:846-848.
117. Singleton BK, Green CA, Avent ND, Martin PG, Smart E, Daka A, Narter-Olaga EG, Hawthorne LM, Daniels G. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12-18.
118. Spencer K, de Kok JB, Swinkels DW. Increased total cell-free DNA in the serum of pregnant women carrying a fetus affected by trisomy 21. Prenat Diagn 2003;23:580-583.
119. Stanghellini I, Bertorelli R, Capone L, Mazza V, Neri C, Percesepe A, Forabosco A. Quantitation of fetal DNA in maternal serum during the first trimester of pregnancy by the use of a DAZ repetitive probe. Mol Hum Reprod 2006;12:587-591.
120. Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, Rossier A, Chien XQ, Anker P. The origin and mechanism of circulating DNA. Ann NY Acad Sci 2000;906:161-168.
121. Tang NLS, Leung TN, Zhang J, Lau TK, Lo YMD. Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clin Chem 1999;45:2033-2035.
122. Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006;169:400-404.
123. Tomaiuolo M, Greco P, Grandone E. Early identification in maternal blood of fetal sex in the presence of fetal DNA from previous pregnancies. Int J Gynecol Obstet 2007;96:202-203.
124. Tong YK, Ding C, Chiu RWK, Gerovassili A, Chim SSC, Leung TY, Leung TN, Lau TK, Nicolaides KH, Lo YMD. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem 2006;52: 2194-2202.
125. Traeger-Synodinos J. Real-time PCR for prenatal and preimplantation genetic diagnosis of monogenic diseases. Mol Aspects Med 2006; 27: 176-191.
126. Tsui NBY, Lo YMD. Placental RNA in maternal plasma: Toward noninvasive fetal gene expression profiling. Ann NY Acad Sci 2006; 1075 96-102.
127. Tsui NBY, Chim SSC, Chiu RWK, Lau TK, Ng EKO, Leung TN, Tong YK, Chan KCA, Lo YMD. Systematic micro-array based identification of placental mRNA in maternal plasma: Towards non-invasive prenatal gene expression profiling. J Med Genet 2004;41:461-467.
128. UK National Screening Committee. Screening tests for you and your baby. 2006.
129. van den Heuvel A, Marteau TM. Cultural variation in values attached to informed choice in the context of prenatal diagnosis. Sem Fetal Neonatal Med 2008;13:99-102.
130. Van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LGC, de Haas M. Non-invasive antenatal RHD typing. Transfus Clin Biol 2006;13:53-57.
131. Wagner FF, Kasulke D, Kerowgan M, Flegel WA. Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany. Infusionsther Transfusionsmed 1995;22:285-290.
132. Wataganara T, LeShane ES, Farina A, Messerlian GM, Lee T, Canick JA, Bianchi DW. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Hum Genet 2003; 112 204-208.
133. Wataganara T, Chen AY, LeShane ES, Sullivan LM, Borgatta L, Bianchi DW, Johnson KL. Cell-free fetal DNA levels in maternal plasma after elective first-trimester termination of pregnancy. Fertil Steril 2004a; 81: 638-644.
134. Wataganara T, Peter I, Messerlian GM, Borgatta L, Bianchi DW. Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol 2004b; 104 545-550.
135. Zhu B, Sun Q-W, Lu Y-C, Sun M-M, Wang L-J, Huang X-H. Prenatal fetal sex diagnosis by detecting amelogenin gene in maternal plasma. Prenat Diagn 2005;25:577-581.
136. Zimmermann B, El Sheikhah A, Nicolaides K, Holzgreve W, Hahn S. Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 2005;51:1598-1604.